(Q39258077)

10 September 2017

Neuropharmacological studies on the neuroleptic potential of domperidone (R33812) (English)

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

4 April 2022

main subject

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

4 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

4 April 2022

author name string

B. Costall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37312

4 April 2022

D. H. Fortune

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37312

4 April 2022

R. J. Naylor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A37312

4 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=37312

4 April 2022

publication date

1 May 1979

1 reference

full work available at URL

10 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1979.tb13518.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

http://academic.oup.com/jpp/article-pdf/31/1/344/37760113/j.2042-7158.1979.tb13518.x.pdf

4 April 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

Journal of Pharmacy and Pharmacology

4 April 2022

published in

1 reference

10 September 2017

31

1 reference

10 September 2017

5

1 reference

10 September 2017

344-347

1 reference

Mesolimbic involvement with behavioural effects indicating antipsychotic activity

10 September 2017

3

27

46

Costall

1974

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents

4 April 2022

4

13

353

Costall

1974

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

4 April 2022

5

43

69

Costall

1975

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems

4 April 2022

6

40

9

Costall

1976

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activity

4 April 2022

0 references

Substituted benzamides as cerebral dopamine antagonists in rodents

8

16

333

Elliott

1977

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

4 April 2022

10

27

307

Leysen

1978

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum

4 April 2022

13

50

1

Protais

1976

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1979.TB13518.X

4 April 2022

Identifiers

0 references

1 reference